Doctor Profile

Richard G. Everson
MD

Richard Everson
MD

UCLA Health
300 UCLA Medical Plaza, Suite 420
Los Angeles, CA 90095

Los Angeles

California (CA)

T: 310-825-5111
F: 310-825-9385

Visit: www.uclahealth.org
Neurological Surgery

Neurological Surgery


Profile

Dr. Everson is a board-certified, fellowship-trained neurosurgical oncologist who has expertise in the treatment of primary and metastatic tumors of the brain, spine and skull base. Dr. Everson also specializes in tumor genetic syndromes. He works closely with multidisciplinary teams to individualize patient treatments and coordinates care with the UCLA Brain Tumor Board. Dr. Everson employs the full range of minimally invasive, image-guided, endoscopic, radiosurgery, microsurgical, conventional open and reconstructive techniques to ensure both maximum tumor removal and patient safety. His research focuses on immunotherapy and clinical trials for brain tumors including dendritic cell vaccines, adoptive cell transfer, oncolytic viral therapy and window-of-opportunity trials. As the Director of the UCLA Brain Tumor Fellowship he is integral to the training of future neurosurgical oncologists.

Published In:

Southern California Rising Stars 2022
Southern California Rising Stars 2021
Southern California Rising Stars 2020
Southern California Rising Stars 2019

About Richard Everson

Medical School: Duke University School of Medicine

Graduation Year: 2009

Professional Webpage: https://www.uclahealth.org/richard-everson

Honors and Awards:

  • Brian D. Silber Award (AANS), 2017
  • NIH R25 Award, 2016
  • California Association of Neurological Surgeons Best Abstract Award, 2016
  • American Association of Neurological Surgeons NREF Research Fellowship , 2013
  • Jonsson Cancer Center Foundation Fellowship , 2013
  • UCLA Neurosurgery Resident Award, 2013
  • Eugene A. Stead Research Scholarship, 2007

Special Licenses/Certifications:

  • Certification, The American Board of Neurological Surgery
  • Medical License, Texas Medical Board, Q7685

Professional Activity:

  • UCLA Brain Tumor Fellowship Director
  • Journal of Neuro-Oncology, Ad Hoc Reviewer
  • Cancer Immunotherapy Immunology, Ad Hoc Reviewer
  • Surgical Neurology International, Consulting Editor
  • Congress of Neurological Surgeons, Member
  • American Association of Neurological Surgeons, Member
  • Society for Neuro-Oncology, Member
  • American Association for Cancer Research, Member

Publications, Lectures and Presentations:

Research Papers

  1. Aliabadi H, Vredenburgh JJ, Everson RG, Desjardins A, Friedman HS, McLendon RE, Tucci DL, Sampson JH. Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration. Journal of neuro-oncology. 2010 Jul;98(3):427-30. PMID: 20020179.
  2. Goetz C, Everson RG, Zhang LC, Gromeier M. MAPK signal-integrating kinase controls capindependent translation and cell type-specific cytotoxicity of an oncolytic poliovirus. Molecular therapy: the journal of the American Society of Gene Therapy. 2010 Nov;18(11):1937-46. PMID: 20648000.
  3. Garrett MC, Bilgin-Freiert A, Bartels C, Everson R, Afsarmanesh N, Pouratian N. An evidence-based approach to the efficient use of computed tomography imaging in the neurosurgical patient. Neurosurgery. 2013 Aug;73(2):209-15; discussion 15-6. PMID: 23632759.
  4. Li S, Chou AP, Chen W, Chen R, Deng Y, Phillips HS, Selfridge J, Zurayk M, Lou JJ, Everson RG, Wu KC, Faull KF, Cloughesy T, Liau LM, Lai A. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro-oncology. 2013 Jan;15(1):57-68. PMID: 23115158.
  5. Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of immunotherapy. 2013 Feb;36(2):152-7. PubMed PMID: 23377664.
  6. Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal for immunotherapy of cancer. 2014;2:10. PubMed PMID: 24883189.
  7. Lisiero DN, Soto H, Everson RG, Liau LM, Prins RM. The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells. Journal for immunotherapy of cancer. 2014;2:8. PubMed PMID: 25054063.
  8. Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro Oncol. 2016 Mar;18(3):368-78. doi: 10.1093/neuonc/nov153. Epub 2015 Sep 1. PMID:26330563
  9. Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, Prins RM. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunol Res. 2016 May;4(5):412-8. doi: 10.1158/2326-6066.CIR-15-0240. PMID: 26968205
  10. Chivukula S, Everson R, Tucker A, Linetsky M, Heaney A, Bonelli L, Wang MB, Bergsneider M. The challenging diagnosis and surgical management of a symptomatic seller spine. World Neurosurg. 2016 Mar 24. pii: S1878-8750(16)00465-4. doi: 10.1016/j.wneu.2016.03.046. PMID:27018010
  11. Antonios JP, Soto H, Everson RG, Orpilla J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy T, Liau LM and Prins RM. PD-1 blockade enhances the vaccination-induced immune response in glioma. JCI Insight 2016 Jul 7;1(10). pii: e87059. PMID: 27453950
  12. Ependymoma Group. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era. J Clin Oncol. 2016 2016 Jul 20;34(21):2468-77. doi: 10.1200/JCO.2015.65.7825. PMID:27269943
  13. Tucker A, Boon-Unge K, McLaughlin N, Ibrahim H, Rao N, Martin N, Everson R, Khanlou N. Cerebellar Liponeurocytoma: Relevant Clinical Cytogenetic Findings. J Pathol Transl Med. 2016 Oct 16. doi: 10.4132/jptm.2016.07.24. PMID:27750407
  14. Tucker AM, Niu T, Nagasawa DT, Everson R, Sedighim S, Butriago Blanco MM. CT-negative MRI GRE-positive primary motor cortex contusion causing isolated foot drop. Surg Neurol 2016 Nov 9;7(Suppl 28):S756-S758. PMID: 27904756.
  15. Antonios JP, Soto H, Orpilla J, Shin N, Everson RG, Moughon D, Sedighim S, Yong WH, Du L, Li G, Ellingson B, Radu C, Liau LM and Prins RM. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology (2016) Neuro Oncol. 2017 Jan 23. pii: now287. doi: 10.1093/neuonc/now287. PMID:28115578
  16. Hoffman HA, Li CH, Everson RG, Strunck JL, Yong WH, Lu DC. Primary lung metastasis of glioblastoma multiforme with epidural spinal metastasis: Case report. J Clin Neurosci. 2017 Jul;41:97-99. doi: 10.1016/j.jocn.2017.03.033. Epub 2017 Mar 23.PMID: 28343918
  17. Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10220-10225. Epub 2017 Sep 5. PMID:28874539
  18. Zuckerman SL, Rao G, Rhines LD, McCutcheon IE, Everson RG, Tatsui CE. Interbody distraction and vertebral body reconstruction with polymethylmethacrylate for the treatment of pathological fractures.J Neurosurg Spine. 2017 Dec;27(6):700-708. Epub 2017 Oct 6. PMID:28984511
  19. Everson RG, Hashimoto Y, Freeman JL, Hodges TR, Huse J, Zhou S, Xiu J, Spetzler D, Sanai N, Kim L, Kesari S, Brenner A, De Monte F, Heimberger A, Raza SM. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design. J Neurooncol. 2018 Sep;139(2):469-478 Epub 2018 May 30. PMID:29846894
  20. Freeman JL, Kaufmann AB, Everson RG, DeMonte F, Raza SM. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression. Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):27-36 PMID:29912434
  21. Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. 2019 Feb 25. pii: nyz008 PMID: 30799490
  22. Chakhoyan A, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 Feb 26;9(1):2846. doi: 10.1038/s41598-018-37564-w.PMID: 30808879
  23. Davidson TB, Lee A, Hsu M, Sedighim S, Orpilla J, Treger J, Mastall M, Roesch S, Rapp C, Galvez M, Mochizuki A, Antonios J, Garcia A, Kotecha N, Bayless N, Nathanson D, Wang A, Everson R, Yong WH, Cloughesy TF, Liau LM, Herold-Mende C, Prins RM. Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation. Clin Cancer Res. 2019 Mar 15;25(6):1913-1922. doi: 10.1158/1078-0432.CCR-18-1176. Epub 2018 Nov 29. PMID: 30498094
  24. Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 May 4. pii: noz078. doi: 10.1093/neuonc/noz078. PMID: 31066901
  25. de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA, Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020 Jan 3:1-9. doi: 10.3171/2019.10.SPINE19998. PMID: 31899882
  26. Patel KS, Everson RG, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 May 4;. doi: 10.1093/neuros/nyaa135. [Epub ahead of print] PubMed PMID: 32365185.
  27. Patel KS, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 Sep 9;10(1):14819. doi: 10.1038/s41598-020-71799-w. PubMed PMID: 32908231.
  28. Shah AA, Karhade AV, Park HY, Sheppard WL, Macyszyn LJ, Everson RG, Shamie AN, Park DY, Schwab JH, Hornicek FJ. Updated external validation of the SORG machine learning algorithms for prediction of ninety-day and one-year mortality after surgery for spinal metastasis. Spine J. 2021 Mar 30:S1529-9430(21)00163-7. doi: 10.1016/j.spinee.2021.03.026. PMID: 33798728
  29. Lu Y, Ng AHC, Chow FE, Everson RG, Helmink BA, Tetzlaff MT, Thakur R, Wargo JA, Cloughesy TF, Prins RM, Heath JR. Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1. Nat Commun. 2021 Jun 29;12(1):4031. doi: 10.1038/s41467-021-24293-4. PMID: 34188042
  30. Lee AH, Sun L, Mochizuki AY, Reynoso JG, Orpilla J, Chow F, Kienzler JC, Everson RG, Nathanson DA, Bensinger SJ, Liau LM, Cloughesy T, Hugo W, Prins RM. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nat Commun. 2021 Nov 26;12(1):6938. doi: 10.1038/s41467-021-26940-2. PMID: 34836966
  31. Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2021 Dec 2:noab276. doi: 0.1093/neuonc/noab276. PMID: 34865129
  32. Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021;32:102882. doi: 10.1016/j.nicl.2021.102882. Epub 2021 Nov 12. PMID: 34911188
  33. Al-Holou WN, Suki D, Hodges TR, Everson RG, Freeman J, Ferguson SD, McCutcheon IE, Prabhu SS, Weinberg JS, Sawaya R, Lang FF. Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas. J Neurosurg. 2022 Jan 7:1-11. doi: 10.3171/2021.9.JNS21718. PMID: 34996044
  34. Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Sci Rep. 2022 Jan 20;12(1):1078. doi: 10.1038/s41598-022-05077-2. PMID: 35058510

Lectures & Presentations

  1. Adoptive Transfer Immunotherapy targeting NY-ESO-1 for the Treatment of Glioblastoma. The 17th Annual Scientific Meeting of the Society of Neuro-Oncology, Washington, DC, 2013.
  2. Preclinical Studies of Intratumoral Cellular Immunotherapy for Recurrent Meningiomas with Alloresponsive Cytotoxic T Lymphocytes. 10th Biennial Satellite Tumor Symposium of AANS/CNS Joint Section on Tumors, New Orleans, LA, 2013.
  3. NREF Update: Adoptive Transfer Immunotherapy targeting NY-ESO-1 for the Treatment of Glioblastoma. The 82nd AANS Annual Scientific Meeting, San Francisco, CA, 2014.
  4. PD-1 Inhibition Enhances Dendritic Cell Vaccine-Generated Anti-Tumor Immune Response against Glioblastoma. California Association of Neurological Surgeons meeting, Pismo Beach, CA, 2016.
  5. Immunotherapy Approaches for Malignant Brain Tumors. Part of BK119: Malignant Brain Tumors: State-of-the-Art Treatment. The 84th AANS Annual Scientific Meeting, Chicago, IL, 2016.
  6. Case-matched study of effect of intra-operative MRI on extent of resection and clinical outcome in glioma patient undergoing surgical resection. 21st Annual Scientific Meeting of the Society for Neuro-Oncology Scottsdale, AZ, 2016.  
  7. Tumor lysate-pulsed DC vaccination induces neoantigen-specific T cell responses. 21st Annual Scientific Meeting of the Society for Neuro-Oncology. Scottsdale, AZ, 2016.
  8. Advances in Dendritic Cell Immunotherapy for Malignant Gliomas Baylor Neurosurgery Grand Rounds, Houston, TX, March 2017
  9. Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Less Delay to Systemic Therapy Compared to Open Surgery The 85th AANS Annual Scientific Meeting Los Angeles, CA,
  10. Emerging Approaches in Brain Tumor Immunotherapy The 85th AANS Annual Scientific Meeting Los Angeles, CA,
  11. The Pituitary Pseudocapsule: Applying Principles of Surgical Oncology to Pituitary Tumors Harbor-UCLA Endocrinology Grand Rounds, Torrance, CA March 2018
  12. Brain Metastasis: State-of-the-Art Treatment UCLA Neurosurgery Update, Santa Monica, CA April 2018
  13. Adjuvant Treatments for Lower Grade Gliomas: Multiple Methods to Target Mutant IDH The 86th AANS Annual Scientific Meeting New Orleans, LA, May 2018.
  14. Clinical Trials of Cellular and Viral Therapy for Malignant Gliomas The 86th AANS Annual Scientific Meeting New Orleans, LA, May 2018.
  15. The Role of Surgery in the Management of NF2 UCLA 18th Annual Brain Tumor Conference and NF2 Symposium for patients, families, & caregivers, Los Angeles, CA, May 2018
  16. Ommaya Reservoirs and Intrathecal Chemotherapy Harbor-UCLA Oncology Grand Rounds, Torrance, CA May 2018
  17. Translational Brain Tumor Immunotherapy LABiomed Cancer Biology and Therapeutics Conference, Torrance CA, June 2018
  18. When do we operate on a patient with a Traumatic Brain Injury? Harbor-UCLA’s 4th Annual Critical Care/Trauma/Surgery Conference, Carson, CA, August 2018
  19. Traumatic Brain Injury UCLA David Geffen School of Medicine, Los Angeles, CA, October 2018
  20. Treatment of Brain Metastasis Harbor-UCLA Oncology Grand Rounds, Torrance, CA February 2019
  21. Brain Mapping for Glioma Surgery UCLA Neurosurgery Update, Santa Monica, CA April 2019
  22. Controversies in Trauma Surgery UCLA Neurosurgery Update, Santa Monica, CA April 2019
  23. Surgical Management of NF2 2019 UCLA 18th Annual Brain Tumor Conference and NF2 Symposium for patients, families, & caregivers, Los Angeles, CA, May 2019
  24. Surgery for Primary Malignant Brain Tumors Harbor-UCLA Neurology Grand Rounds, Torrance, CA August 2019
  25. Early vs. Late Surgery for Spine Trauma/SCI Harbor-UCLA’s 5th Annual Critical Care/Trauma/Surgery Conference, Carson, CA, August 2019
  26. Surgery for Malignant Brain Tumors UCLA Neuro-215 Essentials of Neuro-Oncology Graduate Seminar Course, Los Angeles, CA, October 2019
  27. Evidence Based Surgery for Traumatic Brain Injury UCLA ICU of the Future 2020: The Next Decade of Critical Care, Los Angeles, CA, January 2020
  28. Brain Tumor Immunology: Translating Lessons from Primary to Metastatic Tumors UCLA JCCC Research Seminar Series, Los Angeles, CA, November 2020
  29. Evidence Based Surgery for TBI Harbor UCLA Division of Trauma Surgery Grand Rounds, Torrance, CA, November 2020
  30. Neurosurgical Emergencies for the Neurologist Harbor UCLA Neurology Grand Rounds, Torrance, CA, June 2021
  31. Surgery for Malignant Gliomas UCLA Department of Neurosurgery Grand Rounds, Los Angeles, CA, September 2021
  32. Neuro-Oncologic Surgery UCLA Neuro-265 Essentials of Neuro-Oncology Graduate Seminar Course, Los Angeles, CA, October 2021

Chapters

  1. Everson RG, Fomchenko EI, Foulad DS, Lisiero DN, Liau LM. Immunotherapy for Malignant Gliomas. In: Malignant Gliomas: Radiaton Medicine Rounds Volume 3. Editors: Chakravarti A, Fuss M, Charles R.Demon; 2012. p. 289-316.
  2. Everson RG, Liau LM. Malignant Gliomas. In: Neuro-Oncology: The Essentials 3ed. Editors: Bernstein M, Berger MS. Thieme; 2015. p 289-301
  3. Everson RG, Malone CC, Erickson KL, Fomchenko EI, Prins RM, Liau LM, Kruse CA. Genetically Engineered T Cell Immunotherapy for Gliomas and Other Solid Tumors In: Cancer Immunotherapy- Mechanisms of cancer immunity, engineering immune-based therapies and developing clinical trials: Editor: Song J. Bentham Science; 2015 p105-122
  4. Everson RG, Antonios JP, Tucker AM and Liau LM. Dendritic Cell Therapy for Brain Tumors. In: Translational Immunotherapy Gliomas. Editor: Sampson JH. Elsevier; 2017. P 301-321
  5. Antonios, JP, Everson RG, Kruse CK. Immunología del Sistema Nervioso Central e Immunoterapia de los Gliomas. In: Gliomas. Aspectos Clínicos y Quirúrgicos Editor: Zaninovich R. Ediciones Journal; 2017
  6. Everson RG, Antonios JP, Liau LM Cell-Based Immunotherapy of Gliomas In:. Progress in Neurological Surgery: Contemporary Management of Intracranial Gliomas. Part III-Innovative Treatment Modalities p 90-100 Editors: Chernov MF, Muragaki Y, Kesari S, McCutcheon IE. Karger; 2017
  7. Everson RG, Rhines LD. Review of: Feasibility and Safety of En Bloc Resection for Primary Spine Tumors: A Systematic Review by the Spine Oncology Study Group. In: The Fifty Essential Articles that Every Spine Surgeon Should Know. P 61-64 Editors: Vaccaro AR, Wilson JR, Fisher CG. CMC Press 2018
  8. Ferguson SD, Everson RG, Wagner KM, Yeboa DN, McCutcheon IE, Sawaya R. Neurosurgical Management of Single Brain Metastases. In: Adult CNS Radiation Oncology: Principles and Practice. P 431-437. Editors: Chang EL, Brown PD, Lo SS, Saghal A, Suh JH. Springer 2018
  9. Everson RG, Sarmiento JM, Yang I. Neck Pain and Extremity Weakness Following Trauma. In: de Virgilio C., Grigorian A. (eds) Surgery. Springer, Cham 2020
  10. Yang I., Everson RG Loss of Consciousness Following Head Trauma. In: de Virgilio C., Grigorian A. (eds) Surgery. Springer, Cham 2020

Abstracts

  1. Cortese JF, Everson RG, Gowda AL, Alhasan S, Walter RH, Sun Y, Wali A, Pass HI, Eliason JF, Everson, RB. Microarray Expression-Profiling of Gefitinib-Sensitizing EGFR Mutations in Formalin Fixed, Paraffin Embedded Adenocarcinomas of the Lung: A Preliminary Report. Conference Proceedings of American Association for Cancer Research Special Conference: Oncogenomics S3, 2005.  
  2. Cortese JF, Sun Y, Everson RG, Heilbrun LK, Draghici S, Sakr WA, Powell IJ, Everson RB. Transcriptional profiles of paraffin-embedded prostate tumors reveal race-specific patterns and predictors of recurrence. AACR Meeting Abstracts, Apr 2006; 1241 - 1242.  
  3. Everson RG, Goetz C, Sampson JH, Gromeier M. Ras Activation Mediates Recombinant Poliovirus Selective Replication. The 17th International Conference on Brain Tumor Research and Therapy, 2008.
  4. Everson RG, Lisiero DN, Soto H, Liau LM, Prins RM. Adoptive Transfer Immunotherapy Targeting NY-ESO-1 for Treatment of Glioblastoma. The 17th Annual Scientific Meeting and Education Day of the Society of Neuro-Oncology, 2012.
  5. Prins RM, Soto H, Young E, Lisiero DN, Fong B, Everson RG, and Liau LM. Comparison of glioma associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.  The 17th Annual Scientific Meeting and Education Day of the Society of Neuro-Oncology, 2012.  
  6. Everson RG, Lisiero DN, Soto H, Yaghoubian AJ, Antonios JP, Liau LM, Prins RM. Epigenetic Modulation to Enable Adoptive Transfer Immunotherapy Targeting NY-ESO-1 for Treatment of Glioblastoma. The 81st AANS Annual Scientific Meeting, 2013.
  7. Everson RG, Soto H, Ha E, Erickson K, Malone C, Scharnweber R, Young E, Martin N, Yang I, Shafa B, Bergsneider M, Prins R, Liau L, Kruse K. Preclinical Studies of Intratumoral Cellular Immunotherapy for Recurrent Meningiomas with Alloresponsive Cytotoxic T Lymphocytes. 10th Biennial Satellite Tumor Symposium of AANS/CNS Joint Section on Tumors, 2013.  
  8. Scharnweber R, Kato Y, Lin J, Everson R, Soto H, Kruse C, Kasahara N, Liau L, Prins R. Dendritic cell therapy against virally delivered target antigens is effective in a murine model of glioblastoma The 18th Annual Scientific Meeting and Education Day of the Society of Neuro-Oncology 2013.
  9. Jin RM, Everson RG, Safaee M, Lisiero DN, Odesa S, Liau LM, and Prins RM. Cytotoxic T Cell Functional Responsiveness May Predict Clinical Efficacy of Dendritic Cell Vaccination in Glioblastoma Patients. The 18th Annual Society for Neuro-Oncology Meeting, 2013.
  10. Antonios JP, Soto H, Orpilla J, Shin N, Everson R, Liau LM, Prins RM. Therapeutic antiglioma immunity is dependent on vaccination-induced T cell responses and inhibition of iAPC function in the tumor microenvironment. 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 2015.
  11. Antonios JP, Soto H, Orpilla J, Shin N, Everson R, Liau LM, Prins RM. Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response. Society for Immunotherapy of Cancer, 2015.
  12. Everson RG, Antonios JP, Soto H, Orpilla J, Moughon D, Shin N, Yong WH, Du L, Li G, Liau LM, Prins RM. PD-1 Inhibition Enhances Dendritic Cell Vaccine-Generated Anti-Tumor Immune Response against Glioblastoma. California Association of Neurological Surgeons, 2016. Selected for Best Abstract Award
  13. Antonios JP, Soto H, Orpilla J, Shin N, Everson R, Prins, RM, Liau, LM. Glioma-infiltrating iAPCs mediate T cell recruitment to and activation in the tumor microenvironment. 84th American Association of Neurological Surgeons Annual Meeting. 2016.
  14. Tucker A, Nagasawa D, Niu T, Everson R, Terterov T, Bergsneider M, Martin N, Yang I. Daily Serum Sodium Monitoring in Patients Receiving Intravenous Hypertonic Saline after Elective Craniotomy. Western Neurosurgical Society Meeting. 2016.
  15. Everson RG, Antonios JP, Tucker AM, Soto H, Shin N, Rathe S, Popescu F, Largaespada D, Liau LM, Prins RM. Glioblastoma Lysate-pulsed Dendritic Cell Vaccination Induces Immune Response Against Tumor-specific Mutations. Congress of Neurological Surgeons Annual Meeting, 2016.
  16. Tucker AM, Nagasawa DT, Niu T, Everson RG, Terterov S, Garrett M, Lee SJ, Chen CH, Sidu S, Sedighim S, Bergsneider M, Martin NA, Yang I. Frequency of serum sodium monitoring in patients receiving intravenous 3% sodium chloride after elective cranial surgery. Congress of Neurological Surgeons Annual Meeting, 2016.
  17. Antonios JP, Soto H, Everson RG, Orpilla J, Shin NP, Moughon D, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM Tumor-infiltrating myeloid cells mediate adaptive immune resistance in glioblastoma. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  18. Antonios JP, Soto H, Everson RG, Orpilla J, Shin NP, Nathanson D, Harris R, Sadeghi S, Ellingson B, Liau LM, Prins RM. Non-invasive immune monitoring following DC vaccination effectively delineates immune responses in glioblastoma. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  19. Antonios JP, Soto H, Orpilla J, Shin N, Everson RG, Prins RM, Liau LM. Glioma-infiltrating iAPCs mediate T cell recruitment to and activation in the tumor microenvironment. 84th American Association of Neurological Surgeons Annual Meeting. 2016.
  20. Tucker A, Walbom AS, Nguyen DH, Darling M, Everson R, Terterov S, Nastasi AE, Langevin JP. Poster 393 C5 Palsy After Cervical Laminectomy and Fusion: 2 Case Reports. 2016 AAPM&R Annual Assembly Abstracts Volume 8, Issue 9, Supplement, September 2016, Pages S290
  21. Everson RG, Shin NP, Antonios JP, Soto HS, Tucker A, Zaretsky J, Orpilla J, Rathe S, Popescu F, Largaespada D, Liau LM, Prins RM. Tumor lysate-pulsed DC vaccination induces neoantigen-specific T cell responses. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  22. Moughon D, Everson R, Odesa S, Soto H, Billingslea-Yoon E, Sedighim S, Orpilla J, Lin J, Prins R, Liau L. Phase IIa clinical trial evaluating dendritic cell vaccine for the treatment of low-grade gliomas. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  23. Everson RG, Tucker AM, Garrett MC, Harris R, Ellingson B, Prins RM, Liau LM. Case-matched study of effect of intra-operative MRI on extent of resection and clinical outcome in glioma patient undergoing surgical resection. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  24. Antonios JP, Soto H, Everson R, Orpilla J, Shin NP, Nathanson D, Harris R, Sadeghi S, Ellingson B, Liau LM, Prins RM. Non-invasive immune monitoring following DC vaccination effectively delineates immune responses in glioblastoma. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  25. Antonios JP, Soto H, Everson RG, Orpilla J, Shin NP, Moughon D, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Tumor-infiltrating myeloid cells mediate adaptive immune resistance in glioblastoma. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016.
  26. Moughon D, Everson R, Odesa S, Soto H, Billingslea-Yoon E, Sedighim S, Orpilla J, Lin J, Prins R, Liau L. Atim-32. Phase Iia Clinical Trial Evaluating Dendritic Cell Vaccine For The Treatment Of Low-Grade Gliomas. 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2016
  27. Zuckerman S, Everson R, Rao G, McCutcheon I, Rhines L, Tatsui C. Interbody distraction and vertebral body reconstruction with PMMA for the treatment of pathologic fractures. The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves.
  28. Zuckerman S, Chang G, Walsh G, Mehran R, Everson R, Lee S, Rao G, Tatsui C, Rhines L. Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients with Long-term Follow-up. The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves
  29. Everson RG, Feranandes B, Zuckerman S, Rao G, Li J, Ghia A, Amini B, Rhines, L, Tatsui CE. Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Delay to Systemic Therapy Compared to Open Surgery. 85th American Association of Neurological Surgeons Annual Meeting. 2017. Selected for Brian D. Silver Award
  30. Soto H, Antonios J, Everson R, Moughon D, Wang A, Orpilla J, Radu C, Ellingson B, Lee J, Cloughesy T, Phelps M, Czernin J, Liau L, Prins R Nimg-36. Delineation Of Immune Responses After Immunotherapy In Glioblastoma Using Pet And Mri. 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2017.
  31. Antonios J, Soto H, Everson R, Moughon D, Orpilla J, Shin N, Sedighim S, Treger J, Odesa S, Tucker A, Yong W, Li G, Cloughesy T, Liau L, Prins R. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2017.
  32. Lee A, Mochizuki A, Ishihara M, Garcia A, Nathanson D, Wang A, Everson R, Liau L, Prins R Immu-21. Multidimensional Characterization Of Immune Cell Populations In The Glioma Tumor Microenvironment Reveals A Dominant Proportion Of Cells Derived From The Myelo-Monocytic Lineage. 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2018.
  33. Bethel J, Aliche J, Orpilla J, Soto H, Everson R, Davidson T, Wang A, Liau L, Prins R. Immu-37. Vemurafenib Enhances the Cytotoxicity Of Ny-Eso-1 Tcr Engineered T-Cells For Braf Mutant Brain Tumors. 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2018.
  34. Antonios J, Everson R, Soto H, Khattab S, Bethel J, Sun M, Mochizuki A, Lee A, Odesa S, Billinglea-Yoon E, Moughon D, Wang A, Cloughesy T, Prins R, Liau L. Atim-39. Improved Survival Noted In Glioblastoma Patients Treated With Adjuvant Tlr-3 Agonist In Setting Of Autologous Lysate-Pulsed Dc Vaccination. 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2018.
  35. Nghiemphu P, Everson R, Giovannini M, Reider-Demer M, Wainberg Z, Ishiyama A. Cmet-04. Metastatic Gastrointestinal Cancer To The Skull Base Mimicking Nf2. 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2018.
  36. Lee A, Mochizuki A, Ishihara M, Garcia A, Nathanson D, Wang A, Everson R, Liau L, Prins R. Immu-21. Multidimensional Characterization Of Immune Cell Populations In The Glioma Tumor Microenvironment Reveals A Dominant Proportion Of Cells Derived From The Myelo-Monocytic Lineage 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2018.
  37. Lee A, Pan Y, Mochizuki A, Galvez M, Chow F, Nathanson D, Wang A Everson R, Liau L, Xing Y, Prins R. Immu-02. Neoantigens Arising From Alternative Splicing Events May Be Targeted By Tumor Infiltrating Lymphocytes In Glioblastomas. 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2019.
  38. Sun M, Orpilla J, Contreras E, Treger J, Molaie D, Tsang J, Antonios J Wang A, Liau L, Prins R, Everson R, Immu-50. Systemic Adoptive Transfer Immunotherapy With Tcr-Transduced T-Cells Targeting Ny-Eso-1 For Meningioma. 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2019.
  39. Yao J, Nathanson D, Yong W, Salamon N, Lai A, Nghiemphu P, Prins R, Pope W, Czernin J, Everson R, Liau L, Cloughesy T, Ellingson B. Nimg-60. Idh Mutant Gliomas With 1p/19q Co-Deletion Are Less Acidic Than Non-Co-Deleted Gliomas As Measured With Ph-Weighted Amine Cest-Mri And Amino Acid Pet. 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2019.
  40. Mochizuki A, Lee A, Orpilla J, Kienzler J, Galvez M, Chow F, Davidson T, Wang A, Everson R, Liau L, Cloughesy T, Prins R. Tmic-06. Myeloid Populations And The Effect Of Neoadjuvant Pd-1 Inhibition In The Glioblastoma Microenvironment: A Surfaceomic And Transcriptomic Dissection At The Single-Cell Level. 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2019.
  41. Antonios JP, Everson RG, Mochizuki A, Khattab S, Soto H, Romiyo P, Sun MZ, Moughon D, Billingslea-Yoon E, Odesa S, Li G, Kawaguchi E, Salazar A, Yong W, Schlossman J, Ellingson B, Wang AC, Cloughesy TF, Prins RM, Liau LM. Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination. American Association for Cancer Research 2020.
  42. Alvarado A, Tessema K, Patel K, Kawaguchi R, Everson R, Ellingson B, Swarup V, Goldman S, Kornblum H. CSIG-03. Reconciling Tumor Heterogeneity In Glioblastoma Using A Pathway-Based Approach. Neuro-Oncology 22: ii28-ii. SNO 2020
  43. Antonios JP, Everson R, Mochizuki A, Khattab S, Romiyo P, Sun M, Moughon D, Yong W, Wang A, Cloughesy T et al. Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial. Presented at Journal Of Neurosurgery/AANS 2020
  44. Antonios JP, Everson RG, Mochizuki A, Khattab S, Soto H, Romiyo P, Sun MZ, Moughon D, Billingslea-Yoon E, Odesa S et al. Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination. Presented at Cancer Immunology Research/AACR 2020
  45. Chavez C, Everson R, Orpilla J, Lee A, Khattab S, Antonios J, Salazar A, Cloughesy T, Liau L, Sun L. Dendritic Cell Vaccination In Conjunction With Adjuvant TLR-3 Agonist Administration Enhances Pro-Inflammatory Immune Responses And Is Associated With Extended Survival In Malignant Glioma Patients. Presented at Neuro-Oncology/SNO 2020
  46. Hagiwara A, Yao J, Raymond C, Morrow D, Mareninov S, Chun S, Nathanson D, Yong W, Czernin J, Divakaruni A et al. NIMG-49. Validation Of Simultaneous PH-And O2-Weighted Molecular MRI Using 18f-FDG PET, Immunohistochemistry, And Bioenergetics. Neuro-Oncology 22: ii158-ii9. SNO 2020
  47. Lee A, Mochizuki A, Chow F, Reynoso J, Orpilla J, Sun L, Chavez C, Galvez M, Kienzler J, Yong W et al. IMMU-20. Single-Cell Rnaseq Of Tumor Infiltrating Immune Cells From Neoadjuvant Anti-Pd1 Treated Gbm Patients Reveals Global Transcriptional Changes And Immunosuppressive Adaptive Responses By Myeloid Cells. Neuro-Oncology 22: ii108-ii9. SNO 2020
  48. Patel K, Kawaguchi R, Alvarado A, Muthukrishnan D, Everson R, Liau L, Geschwind D, Ellingson B, Kornblum H. STEM-05. Single Cell Sequencing Characterizes Spatial And Temporal Relationships Of Enhancing And Non-Enhancing Regions In High-Grade Glioma. Neuro-Oncology 22: ii197-ii. SNO 2020
  49. Patel KS, Kawaguchi R, Everson RG, Liau LM, Ellingson B, Kornblum HI. Single Cell Sequencing of Image Guided Biopsies Identifies Spatial and Temporal Heterogeneity in High Grade Glioma. Neurosurgery 67: nyaa447_831CNS 2020
  50. Deng J, Parikh N, Levin-Epstein R, Li M, Tenn S, Lee C, Agazaryan N, Chu F, Yang I, Everson R et al. Single-Isocenter, Multi-Metastasis, Linear Accelerator-Based Stereotactic Radiosurgery For Multiple Brain Metastases. International Journal of Radiation Oncology, Biology, Physics 108: e671 2020
  51. Prins R, Galvez M, Amouzgar M, Campbell K, Wells D, Bayless N, Everson R, Cloughesy T. Molecular And Genetic Determinants Of Response To PD-1 Blockade In Recurrent Glioblastoma Patients. Presented at NEURO-ONCOLOGY. SNO 2020
  52. Sun L, Kienzler J, Lee A, Chow F, Chavez C, Yong W, Everson R, Kim W, Hugo W, Prins R. Neoadjuvant PD-1 Antibody Blockade Remodels The Immune Microenvironment Of Metastatic Brain Tumors. Presented at NEURO-ONCOLOGY. SNO 2020
  53. Wang AC, Owens G, Lee A, Sun MZ, Peeters S, Kienzler JC, Orpilla J, Contreras E, Treger J, Odesa SK et al. Engineering T Cell Receptors to Target H3. 3G34 Mutant Glioblastoma. Neurosurgery 67: nyaa447_794. CNS 2020
  54. Ellingson B, Yao J, Hagiwara A, Nathanson D, Oughourlian T, Everson R, Salamon N, Pope W, Nghiemphu P, Lai A et al. 2021. BIMG-11. Pharmacodynamic Evaluation Of Idh And Egfr Inhibition In Human Gliomas Using Molecular Mri. Neuro-oncology Advances 3: i3

Educational Background:

Fellowship, MD Anderson Cancer Center, 2017

Residency in Neurosurgery, University of California Los Angeles, 2016

Internship, University of California Los Angeles, 2010

Bachelor of Science, University of Michigan, 2005


Map Location

Additional Locations

Harbor-UCLA Medical Center
1000 West Carson Street
Torrance, CA 90502

What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details


Distribution

Super Doctors appears in top city and regional publications around the U.S.: